ATHR » Topics » Research and Development

This excerpt taken from the ATHR 10-Q filed Apr 24, 2009.

Research and Development

 

     Three Months Ended
March 31,
    % Change  
     2009     2008    

Research and development

   $ 29,045     $ 30,054     (3 )%

% of net revenue

     33 %     26 %  

The decrease in research and development expenses of $1.0 million during the three months ended March 31, 2009 compared to the three months ended March 31, 2008, was primarily due to decreases in tapeout related costs of $1.1 million. In addition, consulting and travel and entertainment costs decreased $1.1 million as a result of cost savings programs implemented over the past two quarters. These decreases were partially offset by additional compensation-related costs of $1.5 million, attributable to a 12% increase in the number of employees engaged in research and development activities to support our product development efforts. We anticipate that research and development expenses will increase in the second quarter of 2009 compared to the first quarter of 2009.

These excerpts taken from the ATHR 10-K filed Feb 13, 2009.

Research and Development

We engage in substantial research and development to develop new products and integrate additional capabilities in product designs. We conduct research into digital and analog semiconductor design, hardware reference board design, software reference code development, systems integration and manufacturing process flow development and perform test emulation, digital design verification and application software development at our corporate headquarters in Santa Clara, California, and at our research and development facilities in Irvine, California, China, Finland, India and Taiwan. We use a number of proprietary design tools and processes that enable us to deliver high-performance wireless capabilities using low-cost manufacturing facilities. We employ a team of engineers with extensive experience in mixed signal design, systems and communications architecture, CMOS technology and software development. Our research and development expense was $121.6 million in 2008, $100.9 million in 2007 and $71.1 million in 2006.

Research and Development

 

     Years Ended December 31,     % Change in
2008
 
     2008     2007    

Research and development

   $ 121,565     $ 100,936     20 %

% of net revenue

     26 %     24 %  

The increase in research and development expenses of $20.6 million during the year ended December 31, 2008 compared to 2007 was primarily due to additional compensation-related costs of $17.2 million, partially attributable to a 19% increase in the number of employees engaged in research and development activities to support our growth in the comparable periods. The headcount increase was due primarily to an expansion of our research and development personnel in our six design centers and to a lesser extent, the additional headcount added as part of the u-Nav acquisition in December of 2007. Of the increase in compensation-related expenses, $4.0 million was due to an increase in stock-based compensation. Further, there were increases in software expenses of $1.7 million and consulting expenses of $1.5 million resulting from increased chip development efforts for new and existing markets.

 

40


Table of Contents

We anticipate that research and development expenses will decrease sequentially in the first quarter of 2009 compared to the fourth quarter of 2008.

Research and Development

 

     Years Ended December 31,     % Change in
2007
 
     2007     2006    

Research and development

   $ 100,936     $ 71,084     42 %

% of net revenue

     24 %     24 %  

The increase in research and development expenses of $29.9 million was partly due to additional compensation-related costs of $21.2 million, primarily attributable to a 34% increase in the number of employees engaged in research and development activities in 2007 to support our growth. The headcount increase was due primarily to an expansion of our research and development personnel in our five design centers and to a lesser extent, the additional headcount acquired as part of the u-Nav acquisition. Of the increase in compensation-related expenses, $5.7 million was due to the increase in stock-based compensation. Further, there were increases in software expenses of $1.6 million, tapeout costs of $1.5 million, product development and testing component expenses of $1.3 million and depreciation expense of $1.1 million, primarily due to increased chip development efforts for new and existing markets.

 

43


Table of Contents
This excerpt taken from the ATHR 10-Q filed Oct 28, 2008.

Research and Development

 

     Three Months Ended
September 30,
    %     Nine Months Ended
September 30,
    %  
     2008     2007     Change     2008     2007     Change  

Research and development

   $ 30,859     $ 25,772     20 %   $ 90,860     $ 74,006     23 %

% of net revenue

     22 %     24 %       24 %     24 %  

The increase in research and development expenses of $5.1 million during the three months ended September 30, 2008 compared to the three months ended September 30, 2007, was primarily due to additional compensation-related costs of $4.7 million, partly attributable to a 34% increase in the number of employees engaged in research and development activities to support our growth in the comparable periods. The headcount increase was due primarily to an expansion of our research and development personnel in our five design centers and to a lesser extent, the additional headcount added as part of the u-Nav acquisition in December of 2007. Of the increase in compensation-related expenses, $601,000 was due to an increase in stock-based compensation. This increase in compensation-related costs was partially offset by a decrease in acquisition-related deferred compensation of $1.1 million. We anticipate that research and development expenses will increase in absolute dollars in the fourth quarter of 2008 compared to the third quarter of 2008.

The increase in research and development expenses of $16.9 million during the nine months ended September 30, 2008, compared to the nine months ended September 30, 2007, was primarily due to an increase in compensation-related costs of $14.4 million, partly attributable to a 34% increase in the number of employees engaged in research and development activities at the end of the periods. Of the increase in compensation-related expenses, $2.6 million was due to an increase in stock-based compensation. In addition, software related expenses increased $1.3 million, primarily attributable to increased licensing of development tools to support our engineering efforts.

This excerpt taken from the ATHR 10-Q filed Aug 1, 2008.

Research and Development

 

     Three Months Ended
June 30,
    %
Change
    Six Months Ended
June 30,
    %
Change
 
     2008     2007       2008     2007    

Research and development

   $ 29,947     $ 24,628     22 %   $ 60,001     $ 48,234     24 %

% of net revenue

     25 %     24 %       26 %     24 %  

The increase in research and development expenses of $5.3 million during the three months ended June 30, 2008 compared to the three months ended June 30, 2007, was primarily due to additional compensation-related costs of $4.9 million, partly attributable to a 29% increase in the number of employees engaged in research and development activities to support our growth in the comparable periods. The headcount increase was due primarily to an expansion of our research and development personnel in our five design centers and to a lesser extent, the additional headcount added as part of the u-Nav acquisition in December of 2007. Of the increase in compensation-related expenses, $1.2 million was due to an increase in stock-based compensation. We anticipate that research and development expenses will increase in absolute dollars in the third quarter of 2008 compared to the second quarter of 2008.

The increase in research and development expenses of $11.8 million during the six months ended June 30, 2008, compared to the six months ended June 30, 2007, was primarily due to an increase in compensation-related costs of $9.7 million, partly attributable to a 29% increase in the number of employees engaged in research and development activities at the end of the periods. Of the increase in compensation-related expenses, $2.0 million was due to an increase in stock-based compensation.

This excerpt taken from the ATHR 10-Q filed May 1, 2008.

Research and Development

 

     Three Months Ended
March 31,
       
     2008     2007     %
Change
 

Research and development

   $ 30,054     $ 23,606     27 %

% of net revenue

     26 %     25 %  

The increase in research and development expenses of $6.4 million during the three months ended March 31, 2008 compared to the three months ended March 31, 2007, was partly due to additional compensation-related costs of $4.7 million, primarily attributable to a 32% increase in the number of employees engaged in research and development activities to support our growth in the comparable periods. The headcount increase was due primarily to an expansion of our research and development personnel in our five design centers and to a lesser extent, the additional headcount added as part of the u-Nav acquisition in December of 2007. Of the increase in compensation-related expenses, $808,000 was due to an increase in stock-based compensation. We anticipate that research and development expenses will increase in absolute dollars in the second quarter of 2008 compared to the first quarter of 2008.

These excerpts taken from the ATHR 10-K filed Feb 28, 2008.

Research and Development

 

     Years Ended December 31,     % Change in
2006
 
     2006     2005    

Research and development

   $ 71,084     $ 47,788     49 %

% of net revenue

     24 %     26 %  

The increase in research and development expenses was partly due to an increase in compensation-related costs of $15.9 million, primarily attributable to a 111% increase in the number of employees engaged in research and development activities in 2006. The headcount increase was due both to an expansion of development personnel at our headquarters and was a result of the additional headcount acquired from the ZyDAS and Attansic acquisitions. Additionally, $5.6 million of the increase in compensation-related expenses was due to the increase in stock-based compensation as a result of the adoption of SFAS No. 123R. Further, there were increases in consulting fees and recruiting expenses of $2.9 million, equipment-related expenses of $1.4 million costs of depreciation of $987,000 and tapeout costs of $769,000, primarily due to increased chip development efforts for new and existing markets.

Research and Development

 




























































   Years Ended December 31,  % Change in
2006
 
   2006  2005  

Research and development

  $71,084  $47,788  49%

% of net revenue

   24%  26% 

The increase in research and development expenses was partly due to an increase in
compensation-related costs of $15.9 million, primarily attributable to a 111% increase in the number of employees engaged in research and development activities in 2006. The headcount increase was due both to an expansion of development personnel at
our headquarters and was a result of the additional headcount acquired from the ZyDAS and Attansic acquisitions. Additionally, $5.6 million of the increase in compensation-related expenses was due to the increase in stock-based compensation as
a result of the adoption of SFAS No. 123R. Further, there were increases in consulting fees and recruiting expenses of $2.9 million, equipment-related expenses of $1.4 million costs of depreciation of $987,000 and tapeout costs of $769,000,
primarily due to increased chip development efforts for new and existing markets.

This excerpt taken from the ATHR 8-K filed Feb 22, 2008.

Research and development

Research and development costs consisted of expenditures incurred during the course of planned research and investigation aimed at the discovery of new knowledge that will be useful in developing new products or at significantly enhancing existing products as well as expenditures incurred for the design and testing of product alternatives. All expenditures related to research and development activities of the Company are charged to operating expenses as incurred.

 

Page 7 of 15


 

ATTANSIC TECHNOLOGY CORPORATION

Notes to the consolidated financial statements

nine-month periods ended September 30, 2006 and 2005 (unaudited) and year ended December 31, 2005

(in thousands of New Taiwan dollars, unless specified otherwise)

 

2. Accounting policies (continued)
This excerpt taken from the ATHR 10-Q filed Nov 6, 2007.

Research and Development

 

    

Three Months Ended

September 30,

   

Nine Months Ended

September 30,

 
     2007     2006     %
Change
    2007     2006     %
Change
 

Research and development

   $ 25,772     $ 18,314     41 %   $ 74,006     $ 51,745     43 %

% of net revenue

     24 %     23 %       24 %     24 %  

The increase in research and development expenses during the three months ended September 30, 2007, compared to the three months ended September 30, 2006, was primarily due to an increase in compensation-related costs of $6.0 million, including an increase of $1.7 million related to stock compensation pursuant to the provisions of Statement of Financial Accounting Standards No. 123 (revised 2004), Share-Based Payment, (“SFAS 123R”). This partly relates to a 44% increase in the number of employees engaged in research and development activities at the end of the periods. The increase in research and development personnel resulted from both normal hiring to support the growth of our business and the addition of employees in connection with the Attansic acquisition. In addition, there were increases in research and development component expenses of $1.1 million due to increased chip development efforts for new and existing markets. These increases were partly offset by a $656,000 decrease in consulting and outside service expenses resulting from the completion of certain projects.

The increase in research and development expenses during the nine months ended September 30, 2007, compared to the nine months ended September 30, 2006, was primarily due to an increase in compensation-related costs of $17.0 million, including an increase of $3.8 million related to stock compensation pursuant to the provisions of SFAS 123R. This partly relates to a 44% increase in the number of employees engaged in research and development activities at the end of the periods. In addition, there were increases in software licensing expense of $1.2 million, depreciation expense of $914,000, research and development component expenses of $640,000 and mask and wafer expenses of $616,000, primarily due to increased chip development efforts for new and existing markets.

This excerpt taken from the ATHR 10-Q filed Aug 9, 2007.

Research and Development

 

    

Three Months Ended

June 30,

   

%
Change

   

Six Months Ended

June 30,

   

%
Change

 
     2007     2006       2007     2006    

Research and development

   $ 24,628     $ 17,902     38 %   $ 48,234     $ 33,431     44 %

% of net revenue

     24 %     25 %       24 %     25 %  

The increase in research and development expenses during the three months ended June 30, 2007, compared to the three months ended June 30, 2006, was partly due to an increase in compensation-related costs of $4.9 million related to a 77% increase in the number of employees engaged in research and development activities at the end of the periods. The increase in research and development personnel resulted from both normal hiring to support growth of our business and the addition of employees in connection with the ZyDAS and Attansic acquisitions. In addition, there were increases in licensing costs for both software and intellectual property of $881,000, depreciation expense of $320,000 and consulting expenses of $316,000, primarily due to increased chip development efforts for new and existing markets.

The increase in research and development expenses during the six months ended June 30, 2007, compared to the six months ended June 30, 2006, was partly due to an increase in compensation-related costs of $10.9 million, related to a 77% increase in the number of employees engaged in research and development activities at the end of the periods. In addition, there were increases in software expense of $922,000, consulting and outside services of $920,000, depreciation expense of $677,000 and licensing costs for intellectual property of $359,000, primarily due to increased chip development efforts for new and existing markets.

This excerpt taken from the ATHR 10-Q filed May 10, 2007.

Research and Development

 

    

Three Months Ended

March 31,

    %
Change
 
     2007     2006    

Research and development

   $ 23,606     $ 15,529     52 %

% of net revenue

     25 %     25 %  

The increase in research and development expenses during the three months ended March 31, 2007, compared to the three months ended March 31, 2006, was primarily due to an increase in compensation-related costs of $6.0 million, related to a 108% increase in the number of employees engaged in research and development activities, including those employees added through the ZyDAS and Attansic acquisitions. In addition, there were increases in outside services and consulting fees of $572,000, software expense of $412,000, and depreciation expense of $357,000, primarily due to increased chip development efforts for new and existing markets.

This excerpt taken from the ATHR 8-K filed Mar 5, 2007.

Research and development

Research and development costs consisted of expenditures incurred during the course of planned research and investigation aimed at the discovery of new knowledge that will be useful in developing new products or at significantly enhancing existing products as well as expenditures in curred for the design and testing of product alternatives. All expenditures related to research and development activities of the Company are charged to operating expenses as incurred.

 

Page 7 of 15


ATTANSIC TECHNOLOGY CORPORATION

Notes to the consolidated financial statements

nine-month period ended September 30, 2006 (unaudited) and year ended December 31, 2005

(in thousands of New Taiwan dollars, unless specified otherwise)

 

2. Accounting policies (continued)
This excerpt taken from the ATHR 10-K filed Mar 1, 2007.

Research and Development

 

     Years Ended December 31,

    % Change in
2005


 
         2005    

        2004    

   

Research and development

   $ 47,788     $ 42,704     12 %

% of net revenue

     26 %     25 %      

 

The increase in research and development expenses was primarily due to an increase in compensation-related costs of $4.4 million, primarily attributable to a 20% increase in the number of employees engaged in research and development activities in 2005. In addition, there were increases in equipment-related expenses and costs of additional software development licenses of $644,000 related to development of new products.

 

This excerpt taken from the ATHR 10-Q filed Nov 9, 2006.

Research and Development

 

    

Three Months Ended

September 30,

    %
Change
   

Nine Months Ended

September 30,

    %
Change
 
     2006     2005       2006     2005    

Research and development

   $ 18,314     $ 11,943     53 %   $ 51,745     $ 35,006     48 %

% of net revenue

     23 %     26 %       24 %     27 %  

The increase in research and development expenses during the three months ended September 30, 2006, compared to the three months ended September 30, 2005, was partly due to an increase in compensation-related costs of $2,948,000, related to a 74% increase in the number of employees engaged in research and development activities, and partly due to costs related to stock-based compensation, which increased by $1,513,000 resulting from the adoption of SFAS 123R. In addition, there were increases in outside services and consulting fees of $1,047,000 and depreciation expenses totaling $315,000, primarily due to increased chip development efforts for new and existing markets.

The increase in research and development expenses during the nine months ended September 30, 2006, compared to the nine months ended September 30, 2005, was partly due to an increase in compensation-related costs of $6,544,000, due to a 74% increase in the number of employees engaged in research and development activities, and partly due to costs related to stock-based compensation, which increased by $4,366,000 resulting from the adoption of SFAS 123R. In addition, costs related to prototype parts, expensed equipment, mask sets and engineering wafers increased $2,063,000, and outside services and consulting fees increased $1,723,000, primarily due to increased chip development efforts for new and existing markets.

This excerpt taken from the ATHR 10-Q filed Aug 7, 2006.

Research and Development

 

     Three Months Ended
June 30,
          Six Months Ended
June 30,
       
     2006     2005     %
Change
    2006     2005     %
Change
 

Research and development

   $ 17,902     $ 12,131     48 %   $ 33,431     $ 23,063     45 %

% of net revenue

     25 %     28 %       25 %     27 %  

The increase in research and development expenses during the three months ended June 30, 2006, as compared to the three months ended June 30, 2005, was partly due to an increase in compensation-related costs of $2,117,000, due to a 36% increase in the number of employees engaged in research and development activities, and partly due to costs related to stock-based compensation, which increased by $1,333,000 due to the adoption of SFAS 123R. In addition, there were increases in costs related to prototype parts and mask sets totaling $1,346,000, primarily resulting from increased chip development efforts for new and existing markets and to further expand our revenue base in future periods.

The increase in research and development expenses during the six months ended June 30, 2006, as compared to the six months ended June 30, 2005, was partly due to an increase in compensation-related costs of $3,596,000, due to a 29% increase in the number of employees engaged in research and development activities, and partly due to costs related to stock-based compensation, which increased by $2,855,000 due to the adoption of SFAS 123R. In addition, there were increases in costs related to prototype parts, mask sets, equipment and outside services of $2,254,000, primarily resulting from increased chip development efforts for new and existing markets and to further expand our revenue base in future periods.

 

18


This excerpt taken from the ATHR 10-Q filed May 10, 2006.

Research and Development

 

     Three Months Ended
March 31,
    % Change in
2006
 
         2006             2005        

Research and development

   $ 15,529     $ 10,933     43 %

% of net revenue

     25 %     27 %  

The increase in research and development expenses was primarily due to costs related to stock-based compensation, which increased by $1,597,000 due to the adoption of SFAS 123R, and an increase in other compensation-related costs of $1,403,000, due to a 21% increase in the number of employees engaged in research and development activities. In addition, there were increases in costs related to outside services, consulting, equipment and recruiting of $929,000, primarily resulting from increased chip development and recruiting efforts.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki